a developer of pharmaceutical products to treat eye diseases
Industry Biotechnology
A.I.dvisor tells us that KPRX and FRES have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KPRX and FRES's prices will move in lockstep.
Ticker / NAME | Correlation To KPRX | 1D Price Change % | ||
---|---|---|---|---|
KPRX | 100% | +5.88% | ||
FRES - KPRX | 31% Poorly correlated | +18.63% | ||
AKTX - KPRX | 30% Poorly correlated | -6.37% | ||
TCRT - KPRX | 29% Poorly correlated | +0.95% | ||
PTGX - KPRX | 29% Poorly correlated | +5.17% | ||
NRBO - KPRX | 29% Poorly correlated | -2.04% | ||
More |